Files
ComfyUI_frontend/.coderabbit.yaml
Alexander Brown 2ced8a25d4 Add assertive profile to review settings (#13120)
## Summary
Rabbit too nice.
2026-06-25 20:28:49 +00:00

66 lines
4.3 KiB
YAML

issue_enrichment:
auto_enrich:
enabled: true
reviews:
profile: assertive
high_level_summary: false
request_changes_workflow: true
auto_review:
drafts: true
ignore_title_keywords:
- '[release]'
- '[backport'
ignore_usernames:
- comfy-pr-bot
- github-actions
- github-actions[bot]
pre_merge_checks:
override_requested_reviewers_only: true
# Explicitly disable the built-in docstring coverage check, which is
# enabled via organization-level settings. This repo opts out at the
# repo level without affecting other org repos.
docstrings:
mode: 'off'
custom_checks:
- name: End-to-end regression coverage for fixes
mode: error
instructions: |
Use only PR metadata already available in the review context:
- the PR title
- commit subjects in this PR
- The files changed in this PR relative to the PR base (equivalent to `base...head`)
- the PR description.
Do not rely on shell commands.
Do not inspect reverse diffs, files changed only on the base branch, or files outside this PR.
If the changed-file list or commit subjects are unavailable, mark the check inconclusive instead of guessing.
Fail if all of the following are true:
1. The PR title and/or any commit subject in the PR uses bug-fix language such as `fix`, `fixed`, `fixes`, `fixing`, `bugfix`, or `hotfix`.
2. The PR changes files under `src/` or `packages/` related to the main frontend application but the PR does not change at least one file under `browser_tests/`.
3. The PR description lacks a concrete explanation of why an end-to-end regression test was not added.
Do not fail if the changes are exclusively in `apps/website`, just documentation changes, or changes related to CI processes.
The goal is to make sure that fixes include End-to-End regression tests. Do not insist on tests when the PR is not fixing a bug.
Pass otherwise.
When failing, mention which bug-fix signal you found and ask the author to either add or update a Playwright regression test under `browser_tests/` or add a concrete explanation in the PR description of why an end-to-end regression test is not practical.
- name: ADR compliance for entity/litegraph changes
mode: warning
instructions: |
Use only PR metadata already available in the review context: the changed-file list relative to the PR base, the PR description, and the diff content. Do not rely on shell commands.
This check applies ONLY when the PR modifies files under `src/lib/litegraph/`, `src/ecs/`, or files related to graph entities (nodes, links, widgets, slots, reroutes, groups, subgraphs).
If none of those paths appear in the changed files, pass immediately.
When applicable, check for:
1. **Command pattern (ADR 0003)**: Entity state mutations must be serializable, idempotent, deterministic commands — not imperative fire-and-forget side effects. Flag direct spatial mutation (`node.pos =`, `node.size =`, `group.pos =`) outside of a store or command, and any new void-returning mutation API that should produce a command object.
2. **God-object growth (ADR 0008)**: New methods/properties added to `LGraphNode`, `LGraphCanvas`, `LGraph`, or `Subgraph` that add responsibilities rather than extracting/migrating existing ones.
3. **ECS data/behavior separation (ADR 0008)**: Component-like data structures that contain methods or back-references to parent entities. ECS components must be plain data. New OOP instance patterns (`node.someProperty`, `node.someMethod()`) for data that should be a World component.
4. **Extension ecosystem (ADR 0008)**: Changes to extension-facing callbacks (`onConnectionsChange`, `onRemoved`, `onAdded`, `onConfigure`, `onConnectInput/Output`, `onWidgetChanged`), `node.widgets` access, `node.serialize` overrides, or `graph._version++` without migration guidance. These affect 40+ custom node repos.
Pass if none of these patterns are found in the diff.
When warning, reference the specific ADR by number and link to `docs/adr/` for context. Frame findings as directional guidance since ADR 0003 and 0008 are in Proposed status.